Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 2] - Probabilistic simulations and digital twin for...
Read moreSandrine Dury arrives at N-SIDE this November to take the lead of its Life Sciences Business Unit Louvain-la-Neuve, November 23 - N-SIDE, a leading provider of...
Read moreLighthouse will double the amount of active clinical trials managed by N-SIDE to 1,400 within 3 years
Read moreA product's shelf life is a central part of every clinical trial. In some situations, shelf lives can become a problem for clinical supply chain managers,...
Read moreAlthough our solutions are ideally used proactively before the start of a trial to ensure a smooth sailing through the trial's lifecycle, we are sometimes called...
Read moreDesigning high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 1] - The challenges of a cell & gene therapy supply...
Read more"How to plan for success in early phase clinical trials" Forecasting and optimization are often associated with big pharmaceutical companies, ambitious R&D...
Read more"When you say ROI, do you mean return on investment or risk of inaction?" Regarding new technologies, human decision-making is a complicated phenomenon. This is...
Read more"How best in class biopharma companies have reduced their drug waste by 50%" Did you know that the estimated waste level of packaged material in the industry is...
Read more